ArticleCell biochemistry and biophysics2026
Isoorientin 2''-O-rhamnoside from Crotalaria verrucosa: Deep Eutectic Solvent Based Extraction, Silver-Nanoconjugates Functionalization and in Vivo anti-biofilm Effects against MRSA.
Article in Cell biochemistry and biophysics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Crotalaria verrucosa known as Brihatapushpi/Shanapushpi in Ayurveda, is a treasure trove of phytochemicals like phenolics, saponins and alkaloids, and these bioactives are responsible for its diverse therapeutic properties. This study embarks on developing a sustainable method to isolate a natural flavonoid, harboring a rare C-glycoside moiety - Isoorientin 2’’-O-rhamnoside (IO), from C. verrucosa and aims to tap the antimicrobial potency of IO, by conjugating IO with zero-valent silver nanoparticles. Extracts of C. verrucosa were prepared using ethanol-water solvents. Deep eutectic solvents (DES) were synthesized having Bicine as hydrogen bond donor (HBD) and Choline chloride, acetyl choline chloride, CTAB, TBAB and TBAC as hydrogen bond acceptors (HBA) to extract the phytochemicals. Bicine – Choline chloride DES gratifyingly precipitated a single flavonoid C-glycoside (IO). Box-Behnken (BBD) based response surface methodology optimization was executed to enhance the yield of IO from C. verrucosa extract. High yield of IO was obtained at the optimized conditions of Bicine [HBD, 2.023 mM], Choline chloride [HBA, 2.082 mM] and Ultrasonication [46.3 min]. Further, IO was used to biogenically synthesize silver nanoparticle conjugates (IOAgNPs), and high yield of IOAgNPs were obtained with optimum BBD conditions as silver nitrate 3.658 (mM), IO 3.019 (mM), with 48.7 min of sunlight exposure. IOAgNPs exhibited effective antibiofilm activity against drug-resistant pathogen MRSA. IO@AgNPs demonstrated 1.9-fold reduction in an in-vivo zebrafish infection study and no variations were observed in liver structure when treated with IO@AgNPs, making them promising for pharmaceutical and biomedical applications.
Indexed as
Identifiers
41369706What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.